Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. - Wikidata - wikimedia - TriplyDB

Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.

Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.

http://www.wikidata.org/entity/Q33314616

about

A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas Identifying the neck margin status of ductal adenocarcinoma in the pancreatic head by multiphoton microscopy Tissue tolerable plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo.COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis.The anatomic location of pancreatic cancer is a prognostic factor for survival.Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies.Pancreas cancer survival in the gemcitabine era Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis.An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment.Abnormal T regulatory cells (Tregs: FOXP3+, CTLA-4+), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuv Comparison of Uncinate Process Cancer and Non-Uncinate Process Pancreatic Head Cancer.Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.Redefining resection margin status in pancreatic cancer Friday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma.Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma.Resection margin involvement and tumour origin in pancreatic head cancer.Resection margins in pancreatic cancer.Mesopancreas in pancreatic cancer: where do we stand - review of literature Artery first approach to pancreatoduodenectomy: current status.Meta-analysis of radical resection rates and margin assessment in pancreatic cancer.The importance of surgical margins in pancreatic cancer.Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.Peripancreatic fat invasion is an independent predictor of poor outcome following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials.The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.Mesopancreas: A boundless structure, namely the rationale for dissection of the paraaortic area in pancreaticoduodenectomy for pancreatic head carcinoma.Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins.Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas.Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head?Is it time to stop checking frozen section neck margins during pancreaticoduodenectomy?Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectom Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment.Survival estimates after pancreatoduodenectomy skewed by non-standardized histopathology reports.Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins.

P2860

Q26748880-B63118EF-9156-426E-84D6-F0AFAF08EF81 Q28075892-D558D876-AD1B-4B54-84E9-E3C5C95C1A87 Q33870913-F1DD1AE1-E4BD-44AE-ACB4-E82B130847E7 Q34445750-8DBA5B9D-2CDF-4A5E-B395-108AA382AACD Q34502422-03DD0738-BF3D-4257-8326-F7AC349A8B2A Q34599751-F7FBD02B-34E1-4CF5-9AB0-AD4DE1CFB62E Q34664747-D12DC3A4-F173-4779-BD7E-0F143EAC88B0 Q35181008-414926FE-92D6-45CF-889D-BCA09FCC1303 Q36113317-80B9C82A-1791-405F-AE6B-280F40988CF2 Q36609378-4D1F2B0F-9EDC-4AE6-82CF-3087497DE41D Q36744405-D5C8B77A-943D-4370-8389-1CFFA4195EC0 Q37067996-ED90DFA7-E416-4DBC-BB1F-48D514296BB3 Q37187307-4E320F91-4E9B-44BA-B5B3-7D49900971E4 Q37305587-88AFCC45-331B-45D6-84E7-1D9185711A29 Q37480826-ADF73EF8-D1C7-4CD1-995B-55F5E324C802 Q37538915-9121C544-45E2-47B0-8B5C-3587965D77F5 Q37722157-A778988D-1612-417F-89FD-2C87EFA54812 Q37722822-3327B16F-A627-4BD2-8E3B-83D5D6C71B50 Q38003878-B0928E65-0181-40B6-A538-1C4F94BC7749 Q38160324-22D9C343-4CA6-4268-9629-531CF5A683F6 Q38456837-8E8A6F9C-4D07-42D2-96A1-66DDD8E82FE1 Q38561432-C045983F-6E2B-4758-9BD9-091850B08B43 Q38582990-E986BF61-F011-4E8C-BC6B-FFFD75069515 Q38646898-9AC12872-52DB-4B3C-B3ED-490660428912 Q38927638-EDFEBC79-A7F3-4107-9F73-E1FA9D75E637 Q39811833-E1AA5194-CD34-48D5-A024-150C021AE823 Q39879407-BE523A19-B146-40F1-A7EF-27A40525DBEE Q40563842-AF4123BC-6056-45FA-A410-3DC222CC4FB0 Q43183747-59261F50-344B-4BF7-B6F7-FCF5EA717690 Q44133912-4F324C42-2C0B-4176-8673-969D8D845734 Q44260617-F3A3DBEC-A816-47B8-8AA6-E7254B736E68 Q44453625-1657FC1B-B74D-4C04-9C5E-15FE8867A4BE Q45392240-9A2FAF45-D3BB-4625-8D63-75FB49A9C943 Q47282943-D5DF036F-6D71-48D3-A2BE-DE87F4B17649 Q52339747-15D660B1-04F8-4534-A6B0-D48A46F99B2B Q52838759-9101E515-BB7E-4171-918B-E25096C57DBD Q52844421-30B30941-555B-44A1-B831-583502981308 Q53088925-C0A8C5E7-0EE2-4B84-B97C-7CB3A3797C59 Q55119439-35793F60-DBAA-4060-9EE3-69F2E2A533A3

P2860

Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.

http://www.wikidata.org/entity/Q33314616

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Resectable adenocarcinomas in ...... independent prognostic factor.

@ast

Resectable adenocarcinomas in ...... independent prognostic factor.

@en

Resectable adenocarcinomas in ...... independent prognostic factor.

@nl

type

label

Resectable adenocarcinomas in ...... independent prognostic factor.

@ast

Resectable adenocarcinomas in ...... independent prognostic factor.

@en

Resectable adenocarcinomas in ...... independent prognostic factor.

@nl

prefLabel

Resectable adenocarcinomas in ...... independent prognostic factor.

@ast

Resectable adenocarcinomas in ...... independent prognostic factor.

@en

Resectable adenocarcinomas in ...... independent prognostic factor.

@nl

P1433

Q33314616-322DD244-6327-4D25-96F7-DDCA642B7074

P1476

Q33314616-AA89F632-603F-46D0-B347-FE38E9A6B2D7

P2093

Q33314616-16249729-E75D-4F21-93E0-D3D0049C57A0

Q33314616-28B41B5B-2B8A-47B9-8213-A7392374640A

Q33314616-2EF13FA3-6549-46F7-9826-52294CF19E3D

Q33314616-350BAEC8-66ED-430E-B786-606B3926DFA4

Q33314616-920E9575-0185-4AE0-BBA7-DD2A2F1C1088

Q33314616-991C0838-AF5B-4CBD-99A7-C9F0F6943750

Q33314616-A59C4034-1DD2-40A0-AB57-58358D5ED20F

P2860

Q33314616-05454A51-FA8B-45CD-9EBA-BF188570DBE9

Q33314616-0F8A5F9B-45D3-4131-87EE-A3C90708EB9A

Q33314616-16EBE434-5F7A-4EBD-B196-986C0A376902

Q33314616-28DACB47-9C75-464C-8B53-1B7499E40B34

Q33314616-3EE28586-C08E-4088-A12C-DB290BC5E74A

Q33314616-42661784-EDF1-429A-8468-558905A51E74

Q33314616-42F19BA6-98CD-439E-AEB0-F3091ACF8B45

Q33314616-5B3F8724-4868-44AC-8258-3BEEB7D6FBEB

Q33314616-5C7CC352-D3DC-4D5A-B218-E9E23EC8E918

Q33314616-749A3D44-A28A-4392-8F29-A9E7C50CA9A3

P2888

Q33314616-C1F537A5-0F50-4C80-90A9-F41E4FBC550E

P304

Q33314616-24FF488B-7CE2-49A6-957E-78978797E3D8

P31

Q33314616-322BFB44-9981-46F4-8C33-6698505B1D2C

P356

Q33314616-95FB48D2-10C7-461A-A33F-AE195EF9ADE1

P407

Q33314616-17620529-1A1B-4DDF-A925-2B0E504B48A2

P478

Q33314616-8AE81C10-F0FE-43C5-A12C-5FC14D2B38AD

P50

Q33314616-72959855-147B-419C-8F59-197A95C4825C

P577

Q33314616-9E6666F8-E802-45E6-9AB2-54BCB0B94C53

P5875

Q33314616-9EABF512-CD2C-4B53-8186-FA0D9A8FA574

P6179

Q33314616-C81BF90B-D54A-4FF7-AC2D-FFF049295288

P698

Q33314616-F4E6FE74-29D1-4328-97BE-E829A7995EE9

P921

Q33314616-E06ED786-AED9-4FDB-A270-FED024A6B2B6

P932

Q33314616-23504554-F291-4E20-B5D7-11DF66C5EB4A

P356

P1433

P1476

Resectable adenocarcinomas in ...... independent prognostic factor.

@en

P2093

Arne Westgaard

http://www.w3.org/2001/XMLSchema#string

Inger N Farstad

http://www.w3.org/2001/XMLSchema#string

Milada Cvancarova

http://www.w3.org/2001/XMLSchema#string

Ole Petter F Clausen

http://www.w3.org/2001/XMLSchema#string

Oystein Mathisen

http://www.w3.org/2001/XMLSchema#string

Svetlana Tafjord

http://www.w3.org/2001/XMLSchema#string

Tor J Eide

http://www.w3.org/2001/XMLSchema#string

P2860

The gross anatomy and histology of the gallbladder, extrahepatic bile ducts, Vaterian system, and minor papilla.

Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis.

Pancreaticoduodenectomy: a 20-year experience in 516 patients.

Predicting survival after surgical resection for pancreatic ductal adenocarcinoma.

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.

Factors influencing survival after resection for periampullary neoplasms.

Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

P2888

P304

5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-8-5

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Ivar Prydz Gladhaug

P577

2008-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5656021

http://www.w3.org/2001/XMLSchema#string

P6179

1012516127

http://www.w3.org/2001/XMLSchema#string

P698

18194510

http://www.w3.org/2001/XMLSchema#string

P921

P932

2249586

http://www.w3.org/2001/XMLSchema#string